Generated: April 30, 2017
|Title:||Intermediates for N-substituted carbamoyloxyalkyl-azolium derivatives|
|Abstract:||N-substituted carbamoyloxyalkyl-azolium derivatives which have antifungal activity and are useful for the treatment of fungal diseases.|
|Inventor(s):||Fukuda; Hiroshi (Tokyo, JP), Hayase; Tadakatsu (Chigasaki, JP), Mizuguchi; Eisaku (Kamakura, JP), Shimma; Nobuo (Chigasaki, JP), Ohwada; Jun (Kamakura, JP), Oikawa; Nobuhiro (Kawasaki, JP), Sakaitani; Masahiro (Chigasaki, JP), Tsukazaki; Masao (Fujisawa, JP), Umeda; Isao (Yokohama, JP)|
|Assignee:||Basilea Pharmaceutica AG (CH)|
|Filing Date:||Sep 03, 2004|
|Claims:||1. The compound having the formula: ##STR00037## wherein R.sup.1 is hydrogen or alkyl; R.sup.2 is hydrogen, alkyl, alkylcarbonyloxyalkyl, alkoxycarbonyl, alkylcarbonyl, mono- or dialkylaminoalkylcarbonyloxyalkyl; group ##STR00038## is pyridin-2-yl; L is a chloro, bromo, iodo, tosyloxy or mesyloxy; R.sup.4 and R.sup.5 are independently selected from the group consisting of hydrogen, halogen, alkyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, carboxy, alkyloxycarbonyl, cyano, trifluoromethyl, trifluoromethoxy, nitro, aminosulfonyl, alkylaminocarbonyloxyalkyl, and sulfo, R.sup.4 and R.sup.5 are in addition alkylcarbonyloxyalkyl or aminoalkylcarbonyloxyalkyl and R.sup.6 is hydroxy, alkoxycarbonylalkylamino, alkoxycarbonylamino, amino, alkylamino, alkylcarbonyloxy, alkoxycarbonylalkylaminoalkylcarbonyloxy, alkoxycarbonylaminoalkylcarbonyloxy, alkylaminoalkylcarbonyloxy, aminoalkylcarbonyloxy, alkylcarbonylamino, alkylcarbonylalkylamino, acyloxy, acylamino, or acylalkylamino. |
2. The compound of claim 1 wherein the pyridin-2-yl group is substituted with alkylaminoalkylcarbonyloxyalkyl, alkylcarbonyloxyalkyl, or aminoalkylcarbonyloxyalkyl.
3. The compound of claim 1 wherein R.sup.4 and R.sup.5 are independently selected from the group consisting of hydrogen, halogen, alkoxy, cyano, trifluoromethyl, trifluormethoxy and nitro.
4. The compound of claim 3 wherein R.sup.4 and R.sup.5 are independently selected from the group consisting of hydrogen, halogen and alkoxy.
5. The compound of claim 4 wherein R.sup.4 and R.sup.5 are hydrogen.
6. The compound of claim 1 wherein R.sup.6 is alkylamino, alkylcarbonyloxy, alkylaminoalkylcarbonyloxy or aminoalkylcarbonyloxy.
7. The compound of claim 6 wherein R.sup.6 is alkylaminoalkylcarbonyloxy.
8. The compound of claim 4 wherein said compound is [N-methyl-N-3-((tert-butoxycarbonylmethylamino) acetoxymethl)pyridin-2-yl]carbamic acid 1-chloro-ethyl ester.
9. The compound of claim 4 wherein said compound is [N-methyl-N-3-(acetoxymethyl)pyridin-2-yl]carbamic acid 1-chloro ethyl ester.
10. The compound of claim 4 wherein said compound is [N-methyl-N-3-[(tert-butoxycarbonylamino)acetoxymethyl)pyridin-2-yl]carba- mic acid 1-chloro ethyl ester.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.